ADVANCED POLYMER SYSTEMS TO FILE NDA FOR PROZONE UVA/UVB PROTECTANT
This article was originally published in The Rose Sheet
Executive Summary
ADVANCED POLYMER SYSTEMS TO FILE NDA FOR PROZONE UVA/UVB PROTECTANT during the second quarter of 1994, the company announced Feb. 15. The Redwood City, CA-based firm noted that Phase III safety-in-use trials for ProZone, a prescription melanin-based UVA/UVB sun protectant, have been completed and that Phase III efficacy studies "are nearly completed." Advanced Polymer Systems said it currently is engaged in discussions with FDA "to identify and clarify any potential issues prior to the NDA filing."